Merck
MRK
#59
Rank
NZ$486.02 B
Marketcap
NZ$196.78
Share price
-0.08%
Change (1 day)
47.03%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): NZ$5.97

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$6.10. In 2025 the company made an earnings per share (EPS) of NZ$12.49 an increase over its 2024 EPS that were of NZ$11.59.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$5.97-52.2%
2025NZ$12.497.81%
2024NZ$11.594308.46%
2023NZ$0.26-97.32%
2022NZ$9.8210.92%
2021NZ$8.8584.68%
2020NZ$4.79-27.2%
2019NZ$6.5963.44%
2018NZ$4.03151.11%
2017NZ$1.60-54.58%
2016NZ$3.5330.21%
2015NZ$2.71-61.99%
2014NZ$7.14180.51%
2013NZ$2.54-31.82%
2012NZ$3.736.62%
2011NZ$3.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.97 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.03 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.25-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.19 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.38 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.82 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.39-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$6.10 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.66 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.35-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel